// App-Quantinova.ai

: An observational study of the severity of respiratory depression (RDP) in opioid dependent patients (ODP)

Researchers

Presenter

  • Basak Tas

Principal Investigators

  • Peter S. P. Cho

  • Manuel Lozano Garcia

  • Gerrard F. Rafferty

  • Michael Kelleher

  • John Moxham

  • John Strang

  • Caroline J. Jolley

Medical Centers

  • National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London., London, United Kingdom

  • Division of Asthma, Allergy and Lung Biology, King's College London, London, United Kingdom

  • Biomedical Signal Processing and Interpretation group, Institute for Bioengineering of Catalonia (IBEC) & Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)., Barcelona, United Kingdom

  • Division of Asthma, Allergy and Lung Biology, King's College London, London, United Kingdom

  • Lorraine Hewitt House, Lambeth Addictions Consortium, South London & Maudsley NHS Foundation Trust., London, United Kingdom

  • National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London., London, United Kingdom

  • Centre of Human and Aerospace Physiological Sciences, King's College London and King's College Hospital NHS Foundation Trust, King's Health Partners., London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Depression

Biomarkers

  • Dipeptidase 1

Drug/Treatment

  • Epimorph

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved